Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
818 dias atrás
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1084 dias atrás
U.S. Dollar Falls Against Euro, Pound
The U.S. dollar fell against the euro and the pound in the New York session on Friday.
RTTNews
|
1 dia atrás
Swiss Market Ends On Weak Note
Save for a brief while around mid morning when it edged slightly above the flat line, Switzerland's benchmark index SMI remained in negative territory on Friday amid concerns about high tech valuation and fading hopes of an interest rate cut by the Federal Reserve next month.
RTTNews
|
1 dia atrás
European Markets Close Weak On Growth Concerns, Fading Fed Rate Cut Hopes
European stocks closed weak on Friday amid concerns about high tech valuations, and fading hopes of a Federal Reserve rate cut next month following hawkish comments from a few central bank officials.
RTTNews
|
1 dia atrás
Canadian Market Rebounds From Early Setback; Technology, Energy Stocks Rise
After opening with a big negative gap and dropping further down into the red Friday morning, the Canadian benchmark S&P/TSX Composite Index recovered gradually and was up modestly above the flat line a little past noon.
RTTNews
|
1 dia atrás
Bay Street Likely To Open On Weak Note
Lower Canadian and U.S. futures and weak metal prices point to a negative open for stocks on Bay Street Friday morning. Energy stocks may find some support thanks to higher crude oil prices and help limit the downside.
RTTNews
|
2 dias atrás
FTSE 100 Down Sharply As Bond Yields Climb Higher
UK stocks are falling on Friday with bond yields rising amid speculation Chancellor Rachel Reeves may backtrack on budget plans. The possibility of the Bank of England refraining from cutting interest rates due to fiscal concerns has raised concerns about fiscal and economic outlook.
RTTNews
|
2 dias atrás
